Zheng Cai

ORCID: 0000-0002-4914-7826
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Mechanisms and Therapy
  • Lung Cancer Treatments and Mutations
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Vascular Anomalies and Treatments
  • Vascular Malformations Diagnosis and Treatment
  • Intracranial Aneurysms: Treatment and Complications

Zunyi Medical University
2021-2023

Abstract There is considerable potential for integrating transarterial chemoembolization (TACE), programmed death-(ligand)1 (PD-[L]1) inhibitors, and molecular targeted treatments (MTT) in hepatocellular carcinoma (HCC). It necessary to investigate the therapeutic efficacy safety of TACE combined with PD-(L)1 inhibitors MTT real-world situations. In this nationwide, retrospective, cohort study, 826 HCC patients receiving either plus blockades (combination group, n = 376) or monotherapy...

10.1038/s41392-022-01235-0 article EN cc-by Signal Transduction and Targeted Therapy 2023-02-07

In order to explore the imaging diagnosis methods and interventional treatment effects of hepatocellular carcinoma combined with hepatic arteriovenous fistula (HAVF), a total 120 patients, who were diagnosed as shunting underwent medical surgery therapy at designated hospital by this study from December 2014 2018, chosen subjects. Digital subtraction angiography was performed analyze features HAVF in each patient; then, according these results, gelatin sponge or coil used block fistula;...

10.1155/2021/6651236 article EN cc-by Journal of Healthcare Engineering 2021-03-04
Coming Soon ...